Abstract:It has been previously reported that vascular endothelial growth factor (VEGF) and matrix metalloproteinase (MMP)-9 are important for the occurrence and development of non-small cell lung cancer (NSCLC). The present study was designed to detect the serum levels of VEGF and MMP-9 in NSCLC, and to explore their diagnostic and prognostic values. A total of 543 cases were involved, of which 332 were NSCLC (272 cases in the pretreatment group and 60 cases in the postoperative group), 91 were patients with benign lung diseases and 120 were healthy controls. The serum levels of VEGF and MMP-9 were determined by Luminex multiplex technology. The serum levels of VEGF and MMP-9 were found to be significantly higher in the pretreatment group than those in the patients with benign lung diseases and healthy controls (VEGF, P<0.0001; MMP-9, P<0.0001). Compared with the pretreatment group, the serum levels of VEGF and MMP-9 in the postoperative group were significantly decreased (VEGF, P=0.005; MMP-9, P=0.002), and the levels of VEGF and MMP-9 in the pretreatment group of patients with stages III and IV were higher than those with stages I and II (VEGF, P<0.0001; MMP-9, P=0.021). In addition, the levels of VEGF and MMP-9 were found to closely correlate with lymph node metastasis (VEGF, P<0.0001; MMP-9, P<0.0001) in the pretreatment group, while being independent of other clinicopathological parameters (P>0.05). Furthermore, a positive correlation was observed between the serum levels of VEGF and MMP-9 (r=0.159; P=0.009). A receiver operating characteristic curve analysis showed that the diagnostic value of MMP-9 was higher than that of VEGF in the pretreatment group. The log-rank test indicated that the inoperable NSCLC patients with low levels of VEGF exhibited a significantly longer overall survival time than those with high VEGF levels (P<0.0001). Additionally, the serum levels of VEGF and lymph node metastasis were identified as independent prognostic factors of the inoperable NSCLC patients in a multivariate Cox regression analysis (P<0.05). These results indicated that VEGF and MMP-9 may be potential biomarkers for the diagnosis and prognosis of NSCLC.

The Expression of VEGF and MMP-2 in Non-Small Cell Lung Cancer and Their Association with Pathological Factors and Prognosis

Expression of VEGF and Its Correlation with Prognosis of Small Cell Lung Cancer

The Expression of Vascular Endothelial Growth Factor, Matrix Metalloproteinases 2,9 in Osteosarcoma

Bioinformatics Analyses of the Role of Vascular Endothelial Growth Factor in Patients with Non-Small Cell Lung Cancer.

Expression and clinical study of vascular endothelial growth factor and its receptors FLT-1, FLK-1/KDR in non-small cell lung cancer

Protein expression and significance of VEGF, EGFR and MMP-9 in non-small cell lung carcinomas.

Expression and Clinical Significance of Vascular Endothelial Growth Factor and Epidermal Growth Factor in Non-Small Cell Lung Cancer

Relationship of MMP-2mRNA Expression with Clinical Pathological Features and Prognosis in Gastric Cancer

The Expression and Clinical Significance of Vascular Endothelial Growth Factor-C in Non-small Cell Lung Cancer

Relationship between Expression of Vascular Endothelial Growth Factor C and Malignancy of Non-small Cell Lung Cancer

Relationship between the Expression of MMP-2 and MMP-9 in Non-small Cell Lung Cancer and the Histological Type and Clinical Stage

Detection of circulating vascular endothelial growth factor and matrix metalloproteinase-9 in non-small cell lung cancer using Luminex multiplex technology

Expression and Significance of HIF-1α,GLUT-1 and MMP-2 in Patients with Non-Small Cell Lung Cancer

Prognostic Significance of Overexpressed Matrix Metalloproteinase-2, Mouse-Double Minute: 2 Homolog and Epidermal Growth Factor Receptor in Non-Small Cell Lung Cancer

Studies on the Expression of VEGF in Human Non-Small-Cell Lung Cancer

Expression and prognostic significance of the VEGFR-2 gene in human parenchyma of NSCLC

Expression and Clinicopathologic Significance of NF-kBp65 and MMP-2 in Non-Small Cell Lung Cancer

EXPRESSION OF VASCULAR ENDOTHELIAL GROWTH FACTOR AND BASIC FIBROBLAST GROWTH FACTOR IN HUMAN NON-SMALL CELL LUNG CANCER AND THEIR CLINICAL SIGNIFICANCE

[Expression and Clinical Impact of Vascular Endothelial Growth Factor and Matrix Metalloproteinase-2 in Hepatocellular Carcinoma].

A Study on the Relationship Between Expression of MMP-2,MMP-9 and Metastasis and Prognosis in Patients with Lung Cancer

Expression and Clinical Significance of MMP-26 and MMP-7 in Non-small Cell Lung Cancer